Since tumor cells express PD-L1, the biochemical shield formed by PD-1 binding PD-L1 can protect tumor cells from being recognized and targeted by the immune system, essentially putting the “brakes” on the anti-tumor response of the immune system. The gene discussed is PDCD1; the disease is neoplasm.